CAR T-Cell Therapy and Bispecific Antibodies in Mantle Cell Lymphoma

被引：0
作者：
Kallam, Avyakta [1 ]
Danilov, Alexey [1 ]
Phillips, Tycel J. [1 ]
机构：
[1] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
High risk; CRS; ICANS; bruton tyrosine kinase inhibitor; venetoclax;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S124 / S125
页数：2
相关论文
共 13 条
  • [1] Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
    Budde, Lihua E.
    Sehn, Laurie H.
    Matasar, Matthew
    Schuster, Stephen J.
    Assouline, Sarit
    Giri, Pratyush
    Kuruvilla, John
    Canales, Miguel
    Dietrich, Sascha
    Fay, Keith
    Ku, Matthew
    Nastoupil, Loretta
    Cheah, Chan Yoon
    Wei, Michael C.
    Yin, Shen
    Li, Chi-Chung
    Huang, Huang
    Kwan, Antonia
    Penuel, Elicia
    Bartlett, Nancy L.
    [J]. LANCET ONCOLOGY, 2022, 23 (08) : 1055 - 1065
  • [2] Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy
    Eyre, Toby A.
    Walter, Harriet S.
    Iyengar, Sunil
    Follows, George
    Cross, Matthew
    Fox, Christopher P.
    Hodson, Andrew
    Coats, Josh
    Narat, Santosh
    Morley, Nick
    Dyer, Martin J. S.
    Collins, Graham P.
    [J]. HAEMATOLOGICA, 2019, 104 (02) : E68 - E71
  • [3] Postibrutinib outcomes in patients with mantle cell lymphoma
    Martin, Peter
    Maddocks, Kami
    Leonard, John P.
    Ruan, Jia
    Goy, Andre
    Wagner-Johnston, Nina
    Rule, Simon
    Advani, Ranjana
    Iberri, David
    Phillips, Tycel
    Spurgeon, Stephen
    Kozin, Eliana
    Noto, Katherine
    Chen, Zhengming
    Jurczak, Wojciech
    Auer, Rebecca
    Chmielowska, Ewa
    Stilgenbauer, Stephan
    Bloehdorn, Johannes
    Portell, Craig
    Williams, Michael E.
    Dreyling, Martin
    Barr, Paul M.
    Chen-Kiang, Selina
    DiLiberto, Maurizio
    Furman, Richard R.
    Blum, Kristie A.
    [J]. BLOOD, 2016, 127 (12) : 1559 - 1563
  • [4] Safety and Preliminary Efficacy in Patients with Relapsed/Refractory Mantle Cell Lymphoma Receiving Lisocabtagene Maraleucel in Transcend NHL 001
    Palomba, Maria Lia
    Gordon, Leo I.
    Siddiqi, Tanya
    Abramson, Jeremy S.
    Kamdar, Manali
    Lunning, Matthew A.
    Maloney, David G.
    Andreadis, Charalambos
    Arnason, Jon E.
    Ghosh, Nilanjan
    Mehta, Amitkumar
    Solomon, Scott R.
    Farazi, Thalia
    Garcia, Jacob
    Dehner, Christine
    Ogasawara, Ken
    Gao, Jie
    Wang, Michael
    [J]. BLOOD, 2020, 136
  • [5] Glofitamab Step-up Dosing Induces High Response Rates in Patients (pts) with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL), Most of Whom Had Failed Prior Bruton's Tyrosine Kinase Inhibitor (BTKi) Therapy
    Phillips, Tycel
    Dickinson, Michael
    Morschhauser, Franck
    Bachy, Emmanuel
    Crump, Michael
    Trneny, Marek
    Bartlett, Nancy L.
    Zaucha, Jan
    Humphrey, Kathryn
    Perez-Callejo, David
    Lundberg, Linda
    Relf, James
    de L'Etang, Audrey Filezac
    Carlile, David
    Clark, Emma
    Carlo-Stella, Carmelo
    [J]. BLOOD, 2021, 138
  • [6] Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study
    Song, Yuqin
    Zhou, Keshu
    Zou, Dehui
    Zhou, Jianfeng
    Hu, Jianda
    Yang, Haiyan
    Zhang, Huilai
    Ji, Jie
    Xu, Wei
    Jin, Jie
    Lv, Fangfang
    Feng, Ru
    Gao, Sujun
    Guo, Haiyi
    Zhou, Lei
    Huang, Jane
    Novotny, William
    Kim, Pil
    Yu, Yiling
    Wu, Binghao
    Zhu, Jun
    [J]. BLOOD, 2022, 139 (21) : 3148 - 3158
  • [7] Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial
    Thieblemont, Catherine
    Phillips, Tycel
    Ghesquieres, Herve
    Cheah, Chan Y.
    Clausen, Michael Roost
    Cunningham, David
    Do, Young Rok
    Feldman, Tatyana
    Gasiorowski, Robin
    Jurczak, Wojciech
    Kim, Tae Min
    Lewis, David John
    van der Poel, Marjolein
    Poon, Michelle Limei
    Stirner, Mariana Cota
    Kilavuz, Nurgul
    Chiu, Christopher
    Chen, Menghui
    Sacchi, Mariana
    Elliott, Brian
    Ahmadi, Tahamtan
    Hutchings, Martin
    Lugtenburg, Pieternella J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (12) : 2238 - +
  • [8] Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study
    Wang, Michael
    Munoz, Javier
    Goy, Andre
    Locke, Frederick L.
    Jacobson, Caron A.
    Hill, Brian T.
    Timmerman, John M.
    Holmes, Houston
    Jaglowski, Samantha
    Flinn, Ian W.
    McSweeney, Peter A.
    Miklos, David B.
    Pagel, John M.
    Kersten, Marie Jose
    Bouabdallah, Krimo
    Khanal, Rashmi
    Topp, Max S.
    Houot, Roch
    Beitinjaneh, Amer
    Peng, Weimin
    Fang, Xiang
    Shen, Rhine R.
    Siddiqi, Rubina
    Kloos, Ioana
    Reagan, Patrick M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) : 555 - +
  • [9] Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial
    Wang, Michael
    Rule, Simon
    Zinzani, Pier Luigi
    Goy, Andre
    Casasnovas, Olivier
    Smith, Stephen D.
    Damaj, Gandhi
    Doorduijn, Jeanette
    Lamy, Thierry
    Morschhauser, Franck
    Panizo, Carlos
    Shah, Bijal
    Davies, Andrew
    Eek, Richard
    Dupuis, Jehan
    Jacobsen, Eric
    Kater, Arnon P.
    Le Gouill, Steven
    Oberic, Lucie
    Robak, Taduesz
    Covey, Todd
    Dua, Richa
    Hamdy, Ahmed
    Huang, Xin
    Izumi, Raquel
    Patel, Priti
    Rothbaum, Wayne
    Slatter, J. Greg
    Jurczak, Wojciech
    [J]. LANCET, 2018, 391 (10121) : 659 - 667
  • [10] Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)
    Wang, Michael
    Schuster, Stephen J.
    Phillips, Tycel
    Lossos, Izidore S.
    Goy, Andre
    Rule, Simon
    Hamadani, Mehdi
    Ghosh, Nilanjan
    Reeder, Craig B.
    Barnett, Evelyn
    Bravo, Marie-Laure Casadebaig
    Martin, Peter
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
12